Testing novel biomarkers for treatment
Oncolytic virus therapy in the treatment of melanoma
Results from the PACIFIC study: durvalumab with chemoradiation for the treatment of NSCLC
PROs of the ProtecT trial: is using data provided by patients a good tool for counselling?
Brain metastasis: an important prognostic factor in melanoma